Literature DB >> 22235936

Classification of functional dyspepsia based on concomitant bowel symptoms.

J Matsuzaki1, H Suzuki, K Asakura, Y Fukushima, J M Inadomi, T Takebayashi, T Hibi.   

Abstract

BACKGROUND: Functional dyspepsia (FD) is a heterogeneous disease, and categorized into postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS). However, many FD patients have overlap of both PDS and EPS. The present study was designed to examine whether FD could be categorized based on the presence of concomitant gastrointestinal symptoms.
METHODS: A web survey comprised of the Gastrointestinal Symptom Rating Scale (GSRS), Rome III criteria of FD, and demographic information was sent to public participants who have no history of severe illness. Factor and cluster analyses were conducted to identify sub-categories of FD based on GSRS. KEY
RESULTS: A total of 8038 participants completed the survey. A total of 563 participants met the criteria for FD, whereas 6635 participants did not have dyspepsia symptoms. The remainder had either organic disease (377) or uninvestigated dyspepsia (463). The cluster analysis categorized participants as constipation predominant (cluster C), diarrhea predominant (cluster D), or having neither diarrhea nor constipation (cluster nCnD). Cluster C and D were significantly associated with the presence of FD [odds ratio (OR) 2.57, 95% confidence interval (CI) 2.06-3.21; OR 2.80; 95% CI 2.27-3.45, respectively]. In FD, especially in PDS cases, the scores of upper gastrointestinal symptoms were higher in cluster C or D than in cluster nCnD. CONCLUSIONS & INFERENCES: The severity of dyspepsia symptoms is associated with the presence of bowel symptoms especially in PDS. This novel categorization of FD based on concomitant constipation or diarrhea may improve classification of patients.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22235936      PMCID: PMC3386482          DOI: 10.1111/j.1365-2982.2011.01859.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  24 in total

1.  Gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2010-04       Impact factor: 10.864

2.  Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease.

Authors:  Tomotaka Shindo; Seiji Futagami; Tetsuro Hiratsuka; Akane Horie; Tatsuhiko Hamamoto; Nobue Ueki; Masafumi Kusunoki; Kazumasa Miyake; Katya Gudis; Taku Tsukui; Katsuhiko Iwakiri; Choitsu Sakamoto
Journal:  Digestion       Date:  2009-02-27       Impact factor: 3.216

3.  Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life.

Authors:  Makiko Kaji; Yasuhiro Fujiwara; Masatsugu Shiba; Yukie Kohata; Hirokazu Yamagami; Tetsuya Tanigawa; Kenji Watanabe; Toshio Watanabe; Kazunari Tominaga; Tetsuo Arakawa
Journal:  J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 4.029

4.  Do we have an alternative for the Rome III gastroduodenal symptom-based subgroups in functional gastroduodenal disorders? A cluster analysis approach.

Authors:  L Van Oudenhove; L Holvoet; J Vandenberghe; R Vos; J Tack
Journal:  Neurogastroenterol Motil       Date:  2011-03-30       Impact factor: 3.598

5.  Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.

Authors:  N Manabe; B S Wong; M Camilleri; D Burton; S McKinzie; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2009-12-21       Impact factor: 3.598

6.  Altered gastric emptying in patients with irritable bowel syndrome.

Authors:  A M Caballero-Plasencia; M Valenzuela-Barranco; J M Herrerías-Gutiérrez; J M Esteban-Carretero
Journal:  Eur J Nucl Med       Date:  1999-04

7.  Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study.

Authors:  G Tougas; Y Chen; P Hwang; M M Liu; A Eggleston
Journal:  Am J Gastroenterol       Date:  1999-10       Impact factor: 10.864

8.  Depressive mood and quality of life in functional gastrointestinal disorders: differences between functional dyspepsia, irritable bowel syndrome and overlap syndrome.

Authors:  Heon-Jeong Lee; Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Choon Jo Jin; Seung-Gul Kang; Hiejin Yoon; Hoon Jai Chun
Journal:  Gen Hosp Psychiatry       Date:  2010-06-25       Impact factor: 3.238

Review 9.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

Review 10.  Functional dyspepsia: past, present, and future.

Authors:  Brecht Geeraerts; Jan Tack
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 6.772

View more
  17 in total

1.  To establish a treatment for GI symptoms of cystic fibrosis, it is necessary to develop a symptom evaluation tool.

Authors:  Hidekazu Suzuki
Journal:  United European Gastroenterol J       Date:  2019-06-02       Impact factor: 4.623

2.  Childhood abuse history is associated with the development of dyspepsia: a population-based survey in Japan.

Authors:  Tadayuki Oshima; Hirokazu Fukui; Jiro Watari; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2014-11-22       Impact factor: 7.527

3.  Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial.

Authors:  Boram Lee; O-Jin Kwon; Joo-Hee Kim; Jung Won Kang; Tae-Hun Kim; Seunghoon Lee; Jungeun Kim; Ae-Ran Kim; So Young Jung; Hyo-Ju Park; Sun-Mi Choi
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

Review 4.  Functional dyspepsia--symptoms, definitions and validity of the Rome III criteria.

Authors:  Jan Tack; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-02-12       Impact factor: 46.802

5.  Effect of lansoprazole on the epigastric symptoms of functional dyspepsia (ELF study): A multicentre, prospective, randomized, double-blind, placebo-controlled clinical trial.

Authors:  Hidekazu Suzuki; Hiroaki Kusunoki; Takeshi Kamiya; Seiji Futagami; Yasuharu Yamaguchi; Toshihiro Nishizawa; Eisuke Iwasaki; Juntaro Matsuzaki; Shinichi Takahashi; Choitsu Sakamoto; Ken Haruma; Takashi Joh; Keiko Asakura; Toshifumi Hibi
Journal:  United European Gastroenterol J       Date:  2013-12       Impact factor: 4.623

6.  Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.

Authors:  H Vanheel; F Carbone; L Valvekens; M Simren; H Tornblom; T Vanuytsel; L Van Oudenhove; J Tack
Journal:  Am J Gastroenterol       Date:  2016-12-13       Impact factor: 10.864

7.  Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

8.  Overlap in patients with dyspepsia/functional dyspepsia.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Neurogastroenterol Motil       Date:  2014-09-26       Impact factor: 4.924

Review 9.  The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia.

Authors:  Hidekazu Suzuki
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

10.  Prevalence of Gastric Motility Disorders in Patients with Functional Dyspepsia.

Authors:  Haruki Asano; Toshihiko Tomita; Kumiko Nakamura; Takahisa Yamasaki; Takuya Okugawa; Takashi Kondo; Tomoaki Kono; Katsuyuki Tozawa; Yoshio Ohda; Tadayuki Oshima; Hirokazu Fukui; Kazuhito Fukushima; Shozo Hirota; Jiro Watari; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2017-07-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.